Literature DB >> 8330296

In vitro differentiation of human neuroblastoma cells induced by sodium phenylacetate.

J Cinatl1, J Cinatl1, M Mainke, A Weissflog, H Rabenau, B Kornhuber, H W Doerr.   

Abstract

Sodium phenylacetate (NaPA) at concentrations ranging from 2 to 6 mM stimulated morphological differentiation of two human neuroblastoma cell lines IMR-32 and UKF-NB-3. These concentrations inhibited growth and DNA synthesis of the cells in a dose dependent manner without significant effect on cell viability. The differentiated cells showed pseudoganglia formation and extension of cellular processes. The morphological differentiation in both cell lines was accompanied by decreased expression of N-myc oncoprotein. These results suggest that NaPA at concentrations, which have been achieved in humans with no significant adverse effects, promotes differentiation of cultured human neuroblastoma cells in association with the reduced expression of the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8330296     DOI: 10.1016/0304-3835(93)90069-l

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

Authors:  R Piccoli; S Di Gaetano; C De Lorenzo; M Grauso; C Monaco; D Spalletti-Cernia; P Laccetti; J Cinátl; J Matousek; G D'Alessio
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  Neuroblastoma and MYCN.

Authors:  Miller Huang; William A Weiss
Journal:  Cold Spring Harb Perspect Med       Date:  2013-10-01       Impact factor: 6.915

3.  NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.

Authors:  Ruth Esser; Tina Müller; Dörthe Stefes; Stephan Kloess; Diana Seidel; Stephen D Gillies; Christel Aperlo-Iffland; James S Huston; Christoph Uherek; Kurt Schönfeld; Torsten Tonn; Nicole Huebener; Holger N Lode; Ulrike Koehl; Winfried S Wels
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.